
OrthoPediatrics Corp.
OrthoPediatrics Corp. (KIDS) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · KIDS · as of Jun 8, 2026
Activity summary
Buy transactions
1
P-Purchase only
Sell transactions
5
12 Months
Buy/Sell ratio
0.20
Buy/Sell (by trades)
Overall sentiment
OrthoPediatrics Corp. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
KIDS insider buying and selling by quarter
KIDS insider selling · KIDS insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · KIDS ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
KIDS executive sell shares · KIDS board member insider trading · KIDS insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 13, 2026 | Gerritzen Daniel J General Counsel and Secretary | Gift | 2,479 | — | Form 4 |
| Mar 15, 2026 | Hauser Joseph W Pres. Trauma & Def. Correction | Award | 65,700 | — | Form 4 |
| Mar 16, 2026 | Hauser Joseph W Pres. Trauma & Def. Correction | Sale | 8,596 | $148K | Form 4 |
| Mar 15, 2026 | Hite Fred COO and CFO · Director | Award | 77,405 | — | Form 4 |
| Mar 16, 2026 | Hite Fred COO and CFO · Director | Sale | 12,993 | $224K | Form 4 |
| Mar 16, 2026 | Bailey David R President and CEO · Director | Sale | 19,535 | $337K | Form 4 |
| Mar 15, 2026 | Odle Gregory A President of Scoliosis | Award | 47,380 | — | Form 4 |
| Mar 16, 2026 | Odle Gregory A President of Scoliosis | Sale | 8,433 | $145K | Form 4 |
| Mar 15, 2026 | Gerritzen Daniel J General Counsel and Secretary | Award | 47,380 | — | Form 4 |
| Mar 16, 2026 | Gerritzen Daniel J General Counsel and Secretary | Sale | 8,614 | $149K | Form 4 |
| Dec 29, 2025 | Bailey David R President and CEO · Director | Gift | 1,600 | — | Form 4 |
| Nov 10, 2025 | Fischer Kelly Laine Director | Award | 4,345 | — | Form 4 |
| Aug 21, 2025 | Hite Fred COO and CFO · Director | Purchase | 5,076 | $99K | Form 4 |
| May 23, 2025 | Hughes Bryan W Director | Award | 8,401 | — | Form 4 |
| May 23, 2025 | Infante (Reynolds) Marie C Director | Award | 8,401 | — | Form 4 |
| May 23, 2025 | Ruf Harold Director | Award | 8,401 | — | Form 4 |
| May 23, 2025 | Schlotterback Terry D Director | Award | 8,401 | — | Form 4 |
| May 23, 2025 | McDonald Jimmy Duane Director | Award | 8,401 | — | Form 4 |
| May 23, 2025 | Dyer George Sinclair Mitchell Director | Award | 8,401 | — | Form 4 |
| May 23, 2025 | Pelizzon David R Director | Award | 8,401 | — | Form 4 |
| May 23, 2025 | Riccitelli Samuel D Director | Award | 8,401 | — | Form 4 |
| May 23, 2025 | Throdahl Mark C Director | Award | 8,401 | — | Form 4 |
| Mar 15, 2025 | Gerritzen Daniel J General Counsel and Secretary | Award | 38,773 | — | Form 4 |
| Mar 18, 2025 | Gerritzen Daniel J General Counsel and Secretary | Sale | 5,310 | $132K | Form 4 |
| Mar 15, 2025 | Bailey David R President and CEO · Director | Award | 97,496 | — | Form 4 |
Gerritzen Daniel J
General Counsel and Secretary
Date
May 13
Shares
2,479
Price
—
Value
—
Hauser Joseph W
Pres. Trauma & Def. Correction
Date
Mar 15
Shares
65,700
Price
—
Value
—
Hauser Joseph W
Pres. Trauma & Def. Correction
Date
Mar 16
Shares
8,596
Price
$17.25
Value
$148K
Hite Fred
COO and CFO · Director
Date
Mar 16
Shares
12,993
Price
$17.25
Value
$224K
Bailey David R
President and CEO · Director
Date
Mar 16
Shares
19,535
Price
$17.25
Value
$337K
Odle Gregory A
President of Scoliosis
Date
Mar 16
Shares
8,433
Price
$17.25
Value
$145K
Gerritzen Daniel J
General Counsel and Secretary
Date
Mar 15
Shares
47,380
Price
—
Value
—
Gerritzen Daniel J
General Counsel and Secretary
Date
Mar 16
Shares
8,614
Price
$17.25
Value
$149K
Bailey David R
President and CEO · Director
Date
Dec 29
Shares
1,600
Price
—
Value
—
Hite Fred
COO and CFO · Director
Date
Aug 21
Shares
5,076
Price
$19.41
Value
$99K
Gerritzen Daniel J
General Counsel and Secretary
Date
Mar 15
Shares
38,773
Price
—
Value
—
Gerritzen Daniel J
General Counsel and Secretary
Date
Mar 18
Shares
5,310
Price
$24.86
Value
$132K
Bailey David R
President and CEO · Director
Date
Mar 15
Shares
97,496
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About KIDS insider trading
KIDS insider trades
OrthoPediatrics Corp. (KIDS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Gerritzen Daniel J (General Counsel and Secretary), Hite Fred (COO and CFO · Director), Hauser Joseph W (Pres. Trauma & Def. Correction). Over the past 12 months, 5 insiders have filed transactions with the SEC. KIDS insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For OrthoPediatrics Corp.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
KIDS insider trading · 5 questionsThe insiders of OrthoPediatrics Corp. (KIDS) include executives and directors such as Gerritzen Daniel J (General Counsel and Secretary), Hite Fred (COO and CFO · Director), Hauser Joseph W (Pres. Trauma & Def. Correction), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026